Literature DB >> 1673821

Cell-cycle-related staining patterns of anti-proliferating cell nuclear antigen monoclonal antibodies. Comparison with BrdUrd labeling and Ki-67 staining.

J H van Dierendonck1, J H Wijsman, R Keijzer, C J van de Velde, C J Cornelisse.   

Abstract

Monoclonal antibodies (MAbs) to nuclear antigens are increasingly used as tools to obtain valuable information concerning the proliferative characteristics of various types of cancer. Prerequisite for the application of these MAbs in surgical pathology is establishment of the level of expression and/or cellular distribution of the antigens in relation to distinct cell-cycle compartments. In this study the topologic distribution of proliferating cell nuclear antigen (PCNA), an auxiliary protein of DNA polymerase delta, as recognized by human autoantiserum (AK) and two recently developed MAbs (19A2 and 19F4), was evaluated. Using cultured human cancer cells as a model system, and providing optimal fixation/permeation procedures are applied, these antibodies display a high affinity for PCNA bound to nuclear replicon clusters, resulting in distinct granular staining patterns. A more diffuse nucleoplasmic PCNA staining was mainly restricted to non-S-phase cells; in methanol-fixed cells, staining intensity of this form relative to the replicon-bound form appeared higher after staining with 19A2 than with 19F4 or AK. Comparing PCNA expression (detected with 19A2) with the expression of the Ki-67 antigen, PCNA-negative cells are also Ki-67 negative. In MCF-7 human breast cancer cells treated with 10(-6) mol/l (molar) tamoxifen, the fraction of nuclei showing replication patterns decreased from 42% to 8% within 8 days, but PCNA and Ki-67 antigens remained detectable in most cells during this interval, indicating a relatively slow decrease of antigen expression in cells that have entered a quiescent state. Treatment of MCF-7 cells with 10(-6) mol/l methotrexate resulted in a rapid accumulation of cells with an early S-phase DNA content; PCNA replication patterns showing a frequency distribution reflecting this DNA content were observed up to 48 hours after treatment. This indicates that the presence of replication patterns as visualized with anti-PCNAs is not a measure of replicative activity per se. It is concluded that, providing nuclear non-S-phase PCNA staining is faint relative to staining of replicon clusters, anti-PCNA antibodies may be excellent markers to detect in situ cells with S-phase DNA contents.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673821      PMCID: PMC1886031     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  32 in total

Review 1.  Mammalian DNA polymerases alpha and delta: current status in DNA replication.

Authors:  A G So; K M Downey
Journal:  Biochemistry       Date:  1988-06-28       Impact factor: 3.162

2.  DNA repair synthesis in human fibroblasts requires DNA polymerase delta.

Authors:  C Nishida; P Reinhard; S Linn
Journal:  J Biol Chem       Date:  1988-01-05       Impact factor: 5.157

3.  Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labelling for marking S phase cells in paraffin sections from animal and human tissues.

Authors:  P Galand; C Degraef
Journal:  Cell Tissue Kinet       Date:  1989-09

4.  Immunochemical detection of a primase activity related subunit of DNA polymerase alpha from human and mouse cells using the monoclonal antibody.

Authors:  T Yagura; T Kozu; T Seno; S Tanaka
Journal:  Biochemistry       Date:  1987-12-01       Impact factor: 3.162

5.  Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells.

Authors:  J H van Dierendonck; R Keijzer; C J van de Velde; C J Cornelisse
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

6.  Subdivision of S-phase by analysis of nuclear 5-bromodeoxyuridine staining patterns.

Authors:  J H van Dierendonck; R Keyzer; C J van de Velde; C J Cornelisse
Journal:  Cytometry       Date:  1989-03

7.  Cell cycle phase dependent emergence of thymidylate synthase studied by monoclonal antibody (M-TS-4).

Authors:  S Shibui; T Hoshino; K Iwasaki; K Nomura; M M Jastreboff
Journal:  Cell Tissue Kinet       Date:  1989-05

8.  Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein.

Authors:  G Prelich; C K Tan; M Kostura; M B Mathews; A G So; K M Downey; B Stillman
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

9.  Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta.

Authors:  R Bravo; R Frank; P A Blundell; H Macdonald-Bravo
Journal:  Nature       Date:  1987 Apr 2-8       Impact factor: 49.962

10.  Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication.

Authors:  K Ogata; P Kurki; J E Celis; R M Nakamura; E M Tan
Journal:  Exp Cell Res       Date:  1987-02       Impact factor: 3.905

View more
  40 in total

Review 1.  Proliferation markers in tumours: interpretation and clinical value.

Authors:  P J van Diest; G Brugal; J P Baak
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

2.  Coordinated regulation and colocalization of alphav integrin and its activating enzyme proprotein convertase PC5 in vivo.

Authors:  Philipp Stawowy; Kristof Graf; Stephan Goetze; Mattias Roser; Michel Chrétien; Nabil G Seidah; Eckart Fleck; Mieczyslaw Marcinkiewicz
Journal:  Histochem Cell Biol       Date:  2003-02-20       Impact factor: 4.304

3.  Proliferating cell nuclear antigen in malignant and pre-malignant lesions of epithelial origin in the oral cavity and the skin: an immunohistochemical study.

Authors:  T Tsuji; P Shrestha; K Yamada; H Takagi; F Shinozaki; K Sasaki; K Maeda; M Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

4.  Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.

Authors:  S M Siitonen; O P Kallioniemi; J J Isola
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

5.  PCNA and Ki-67 in central nervous system tumors: correlation with the histological type and grade.

Authors:  Fazilet Kayaselçuk; Suzan Zorludemir; Derya Gümürdühü; Handan Zeren; Tahsin Erman
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

6.  Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma.

Authors:  M Thomas; M Noguchi; H Kitagawa; K Kinoshita; I Miyazaki
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

7.  Immunoreactivity of proliferating cell nuclear antigen in salivary gland tumours: an assessment of growth potential.

Authors:  L Yang; K Hashimura; C Qin; P Shrestha; S Sumitomo; M Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

8.  Proliferating cell nuclear antigen in breast lesions: correlation of c-erbB-2 oncoprotein and EGF receptor and its clinicopathological significance in breast cancer.

Authors:  P Shrestha; K Yamada; T Wada; S Maeda; M Watatani; M Yasutomi; H Takagi; M Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

9.  Pubertal exposure to high fat diet causes mouse strain-dependent alterations in mammary gland development and estrogen responsiveness.

Authors:  L K Olson; Y Tan; Y Zhao; M D Aupperlee; S Z Haslam
Journal:  Int J Obes (Lond)       Date:  2010-03-16       Impact factor: 5.095

10.  Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Comparison with thymidine and bromodeoxyuridine labeling.

Authors:  U Zeymer; M C Fishbein; J S Forrester; B Cercek
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.